Trials / Completed
CompletedNCT01741389
The Role of Melatonin in the Regulation of Blood Coagulation
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- University of Oslo · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The main aim is to examine the influence of daylight and melatonin on the temporal variations of hemostatic factors with key roles in the hemostatic process and its regulation. Particular emphasis will be on exploring the role of melatonin in hemostasis by comparing subjects with tetraplegia with able-bodied control subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Melatonin ("Circadin") |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2014-03-01
- Completion
- 2014-03-01
- First posted
- 2012-12-04
- Last updated
- 2017-10-16
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT01741389. Inclusion in this directory is not an endorsement.